- Home
- NEXT vs BCRX Comparison
NEXT vs BCRX Comparison
Compare NEXT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEXT
- BCRX
- Stock Information
- Founded
- NEXT 2010
- BCRX 1986
- Country
- NEXT United States
- BCRX United States
- Employees
- NEXT N/A
- BCRX N/A
- Industry
- NEXT Oil & Gas Production
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEXT Energy
- BCRX Health Care
- Exchange
- NEXT Nasdaq
- BCRX Nasdaq
- Market Cap
- NEXT 1.9B
- BCRX 1.7B
- IPO Year
- NEXT N/A
- BCRX 1994
- Fundamental
- Price
- NEXT $7.67
- BCRX $9.97
- Analyst Decision
- NEXT Hold
- BCRX Buy
- Analyst Count
- NEXT 1
- BCRX 8
- Target Price
- NEXT $9.00
- BCRX $16.75
- AVG Volume (30 Days)
- NEXT 1.4M
- BCRX 5.9M
- Earning Date
- NEXT 05-06-2025
- BCRX 05-05-2025
- Dividend Yield
- NEXT N/A
- BCRX N/A
- EPS Growth
- NEXT N/A
- BCRX N/A
- EPS
- NEXT N/A
- BCRX N/A
- Revenue
- NEXT N/A
- BCRX $503,485,000.00
- Revenue This Year
- NEXT N/A
- BCRX $27.64
- Revenue Next Year
- NEXT N/A
- BCRX $13.42
- P/E Ratio
- NEXT N/A
- BCRX N/A
- Revenue Growth
- NEXT N/A
- BCRX 41.67
- 52 Week Low
- NEXT $4.27
- BCRX $5.06
- 52 Week High
- NEXT $9.71
- BCRX $11.11
- Technical
- Relative Strength Index (RSI)
- NEXT 52.96
- BCRX 65.89
- Support Level
- NEXT $7.17
- BCRX $9.83
- Resistance Level
- NEXT $7.78
- BCRX $11.11
- Average True Range (ATR)
- NEXT 0.34
- BCRX 0.51
- MACD
- NEXT 0.03
- BCRX 0.20
- Stochastic Oscillator
- NEXT 77.44
- BCRX 68.33
About NEXT NextDecade Corporation
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.